Cardinal Health, Inc. (CAH) vs IDEXX Laboratories, Inc. (IDXX)
A side-by-side comparison of Cardinal Health, Inc. and IDEXX Laboratories, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.
CAH
Cardinal Health, Inc.
$229.12HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT
IDXX
IDEXX Laboratories, Inc.
$569.77HealthcareDelayed quote: Jul 29, 2026, 4:00 PM EDT
Total return — CAH vs IDXX
growth of $100 · dividends reinvested · last 30yCAH +1681.9%IDXX +12201.1%IDXX compounded faster
Log scale — wide-divergence pair
CAH IDXX
CAH vs IDXX: by the numbers
- •CAH is the larger company ($53.66B vs $44.95B market cap).
- •CAH trades at the lower trailing earnings multiple (35.55 vs 42.00 P/E), one valuation lens rather than an overall verdict.
- •IDXX converts more revenue to profit (24.63% vs 0.62% net margin).
- •CAH grew revenue faster over the past five years (9.86% vs 9.24% CAGR).
- •CAH pays a dividend (0.88% yield), while IDXX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CAH | IDXX |
|---|---|---|
| P/E ratio | 35.55 | 42.00 |
| Forward P/E | 21.58 | 38.89 |
| P/S ratio | 0.22 | 10.33 |
| P/B ratio | N/A | 29.53 |
| PEG ratio | 0.30 | 2.31 |
| EV / EBITDA | 18.90 | 30.13 |
| FCF yield | 8.01% | 2.35% |
Profitability
| Metric | CAH | IDXX |
|---|---|---|
| Gross margin | 3.68% | 62.05% |
| Operating margin | 0.92% | 31.63% |
| Net margin | 0.62% | 24.63% |
| ROE | -56.13% | 70.38% |
| ROIC | 11.37% | 40.27% |
Dividends
| Metric | CAH | IDXX |
|---|---|---|
| Dividend yield | 0.88% | N/A |
| Payout ratio | 31.60% | N/A |
Growth (annualized)
| Metric | CAH | IDXX |
|---|---|---|
| Revenue CAGR (5Y) | 9.86% | 9.24% |
| EPS CAGR (5Y) | 6.11% | 14.07% |
| FCF CAGR (5Y) | 22.47% | 10.13% |
| Total return CAGR (5Y) | 34.18% | -3.92% |
Frequently asked
- Which has the lower trailing P/E, CAH or IDXX?
- CAH has the lower trailing P/E: CAH trades at 35.55 and IDXX at 42.00. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, CAH or IDXX?
- Over the past five years, CAH grew revenue faster — CAH at a 9.86% CAGR versus IDXX at 9.24%.
- Does CAH or IDXX pay a bigger dividend?
- CAH pays a dividend (0.88% yield), while IDXX has no payments in the available dividend history.
- Is CAH or IDXX more profitable?
- IDXX runs the higher net margin — CAH at 0.62% versus IDXX at 24.63%.
- How have CAH and IDXX total returns compared?
- Over the past 10 years, CAH delivered 14.04% and IDXX delivered 19.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cardinal Health P/E ratioIDEXX Laboratories P/E ratioCardinal Health dividend yieldIDEXX Laboratories dividend yieldCardinal Health ROEIDEXX Laboratories ROECardinal Health operating marginIDEXX Laboratories operating marginCardinal Health revenue growthIDEXX Laboratories revenue growthCardinal Health free cash flowIDEXX Laboratories free cash flow
Cardinal Health & IDEXX Laboratories appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.